(Q73502964)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9219708%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Anticytokine therapy in rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9219708%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Anticytokine Therapy in Rheumatoid Arthritis (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

14 September 2024

author name string

G. S. Firestein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219708

14 September 2024

N. J. Zvaifler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219708

14 September 2024

language of work or name

English

0 references

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9219708%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

17 July 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9219708

full work available at URL

14 September 2024

http://www.nejm.org/doi/pdf/10.1056/NEJM199707173370310

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

The New England Journal of Medicine

14 September 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9219708%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9219708%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9219708%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

195-197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9219708%20AND%20SRC:MED&resulttype=core&format=json

How important are T cells in chronic rheumatoid synovitis?

4 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

14 September 2024

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

14 September 2024

3

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid

14 September 2024

4

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

14 September 2024

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production b

14 September 2024

6

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis

14 September 2024

7

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

14 September 2024

8

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

14 September 2024

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study

14 September 2024

10

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

14 September 2024

11

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

The Journal of Rheumatology

14 September 2024

12

22

2250

Van Lent PL

1995

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?

14 September 2024

13

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

14 September 2024

15

1 reference

https://api.crossref.org/works/10.1056/NEJM199707173370310

14 September 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9219708%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference